The IPO Buzz: Biopharma’s Back in Play
Just one IPO is in the wings this week – and it hails from the biopharma sector. This isn’t a coincidence. Any time an industrial sector outperforms the broad U.S. stock market, it can catch the investor’s eagle eye. This is what has happened since the three major U.S. stock indexes bottomed out on March 23, 2020 – just two weeks ago. On that date, March 23rd, the S&P 500 Index closed..
Read more April 5, 2020IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Keros Therapeutics | KROS | 5.0 | $ 75.0 mil | 4/8/2020 Wednesday | S/O | S/O |
Last 100 IPOs - April 5, 2020
| Number of IPOs priced : | 100 |
| Number Up: | 37 |
| Number Down: | 63 |
| Number Unchanged: | 0 |
| Percentage Change From Issue Price: | 5.19% |
| Percentage Change for The Nasdaq Composite | -7.91% |
2020 IPO Scorecard - April 5, 2020
| Number of IPOs priced (Excluding 13 units) : | 25 |
| Number Up: | 8 |
| Number Down: | 17 |
| Number Unchanged: | 0 |
| Total Return From Issue Price: | -7.45% |
| The Nasdaq Composite Index YTD % Change | -17.83% |